16:44 EDT Monopar Therapeutics (MNPR) files $300M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNPR:
- Monopar Therapeutics assumed with a Buy at H.C. Wainwright
- Monopar Therapeutics management to meet with Cantor Fitzgerald
- Monopar Therapeutics Reports Increased R&D Expenses
- Monopar Therapeutics reports Q2 EPS (35c), consensus (48c)
- Monopar Therapeutics initiated with an Overweight at Cantor Fitzgerald